See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $472B | 7.7x | 18.1x | |
| $400B | 4.7x | 16.9x | |
| $239B | 4.5x | 19.0x | |
| $190B | 2.8x | 12.7x | |
| $89.9B | 1.7x | 7.9x | |
| $84.6B | 4.2x | 17.2x | |
| $68.4B | 3.5x | 12.8x | |
| $60.5B | 4.0x | 15.9x | |
| $58.8B | 8.2x | 35.8x | |
| $49.0B | 9.1x | 39.6x | |
| $45.5B | 3.1x | 21.3x | |
| $43.8B | 2.9x | 13.1x | |
| $41.8B | 4.3x | 17.6x | |
| $39.9B | 1.6x | 9.0x | |
| $32.7B | 2.7x | 17.9x | |
| $25.8B | 4.2x | 18.3x | |
| $25.2B | 2.2x | 12.3x | |
| $25.0B | 1.6x | 8.7x | |
| $21.9B | 2.1x | 6.0x | |
| $19.0B | 1.8x | 11.6x | |
| $13.6B | 8.1x | 39.3x | |
| $12.7B | 2.1x | 14.3x | |
| $12.6B | 2.1x | 10.4x | |
| $10.7B | 7.6x | 42.5x | |
| $9.9B | 6.4x | 25.7x | |
| $9.7B | 1.6x | 15.3x | |
| $9.7B | 6.7x | 35.7x | |
| $9.4B | 1.5x | 8.8x | |
| $7.3B | 7.4x | 28.6x | |
| $6.3B | 2.2x | 14.3x | |
| $6.2B | 9.3x | 29.1x | |
| $5.5B | 3.7x | 18.3x | |
| $5.2B | 1.2x | 7.2x | |
| $5.2B | 0.9x | 5.0x | |
| $4.8B | 2.2x | 12.7x | |
| $4.7B | 1.6x | 6.9x | |
| $4.6B | 10.9x | 33.2x | |
| $4.3B | 1.3x | 7.3x | |
| $4.2B | 3.7x | 11.4x | |
| $4.2B | 1.3x | 8.2x | |
| $4.1B | 8.4x | 32.7x | |
| $3.7B | 2.3x | 12.3x | |
| $3.4B | 1.6x | 9.7x | |
| $3.3B | 0.7x | 6.1x | |
| $3.3B | 2.3x | 11.1x | |
| $3.2B | 3.7x | 9.0x | |
| $3.2B | 2.6x | 16.1x | |
| $3.1B | 0.9x | 5.9x | |
| $3.0B | 9.1x | 34.0x | |
| $3.0B | 1.3x | 9.6x | |
| $2.8B | 1.1x | 5.9x | |
| $2.7B | 1.0x | 8.0x | |
| $2.6B | 2.4x | 10.9x | |
| $2.4B | 3.0x | 21.6x | |
| $2.4B | 0.5x | 6.9x | |
| $2.4B | 1.1x | 7.8x | |
| $2.3B | 5.3x | 20.0x | |
| $2.2B | 5.6x | 16.3x | |
| $2.1B | 3.6x | 17.7x | |
| $2.0B | 1.2x | 10.4x | |
| $2.0B | 2.8x | 13.3x | |
| $1.9B | 1.7x | 12.5x | |
| $1.8B | 2.4x | 12.2x | |
| $1.8B | 1.0x | 7.6x | |
| $1.7B | 2.1x | 10.4x | |
| $1.7B | 0.8x | 8.9x | |
| $1.7B | 6.3x | 17.8x | |
| $1.7B | n/a | n/a | |
| $1.5B | 1.2x | 8.1x | |
| $1.3B | 0.7x | 6.2x | |
| $1.3B | 1.6x | 6.7x | |
| $1.2B | 1.6x | 10.8x | |
| $1.1B | 2.7x | 12.2x | |
| $1.1B | 0.5x | 4.9x | |
| $1.1B | 0.3x | 2.4x | |
| $1.0B | 4.2x | 59.4x | |
| $998M | 0.8x | 8.1x | |
| $982M | 2.1x | 10.3x | |
| $963M | 1.2x | 6.5x | |
| $888M | 7.0x | 26.3x | |
| $883M | n/a | n/a | |
| $799M | 1.9x | 11.2x | |
| $741M | n/a | n/a | |
| $658M | 0.9x | 7.3x | |
| $652M | n/a | n/a | |
| $570M | 3.3x | 13.0x | |
| $507M | n/a | n/a | |
| $445M | 0.3x | n/a | |
| $407M | 1.5x | 18.5x | |
| $390M | 1.3x | -18.5x | |
| $381M | n/a | n/a | |
| $343M | 1.7x | -36.5x | |
| $324M | 6.3x | 24.0x | |
| $318M | n/a | n/a | |
| $300M | n/a | n/a | |
| $292M | 1.0x | 7.8x | |
| $258M | 0.6x | 7.1x | |
| $238M | n/a | n/a | |
| $229M | 1.6x | 6.8x | |
| $200M | 0.4x | 11.5x | |
| $199M | 1.0x | 9.8x | |
| $190M | 0.9x | 4.0x | |
| $188M | 2.3x | 13.3x | |
| $188M | 0.5x | 8.5x | |
| $155M | 0.8x | 5.6x | |
| $150M | 2.3x | 8.5x | |
| $135M | 0.5x | 6.1x | |
| $117M | 0.5x | 4.7x | |
| $114M | n/a | n/a | |
| $86.1M | n/a | n/a | |
| $74.6M | n/a | n/a | |
| $70.5M | 0.3x | 7.4x | |
| $61.4M | 2.3x | 9.7x | |
| $42.6M | n/a | n/a | |
| $42.4M | 0.9x | n/a | |
| $42.1M | n/a | n/a | |
| $41.2M | n/a | n/a | |
| $27.9M | 2.2x | n/a | |
| $25.1M | n/a | n/a | |
| $21.7M | n/a | n/a | |
| $20.8M | 1.1x | -12.0x | |
| $17.8M | n/a | n/a | |
| $16.2M | n/a | n/a | |
| $9.0M | n/a | n/a | |
| $6.7M | n/a | n/a | |
| $5.1M | n/a | n/a | |
| $0.9M | n/a | n/a | |
| -$42.9M | -0.1x | -71.5x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty